GLEN DASHER: Open Payments
NPI 1972684546 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,506 in 96 payments from 30 companies in 2025. Trend: 2023 $1,808 · 2024 $1,475 · 2025 $1,506
Food & beverage: $1,506
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $170 |
| Amgen Inc. | 18 | $166 |
| ABBVIE INC. | 13 | $147 |
| AstraZeneca Pharmaceuticals LP | 7 | $114 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $99 |
| Lilly USA, LLC | 5 | $88 |
| Teva Pharmaceuticals USA, Inc. | 4 | $69 |
| Astellas Pharma US Inc | 3 | $65 |
| Novo Nordisk Inc | 4 | $60 |
| Boston Scientific Corporation | 2 | $50 |
Products named: OTEZLA, XIFAXAN, AIRSUPRA, ELIQUIS, NURTEC ODT, AUSTEDO XR, Veozah, UBRELVY.
Industry payments across GA — which companies pay providers there.
